Biotin and Naprosyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biotin (biotin) and Naprosyn (naproxen). Common drug interactions include fall among females and hot flush among males.

The phase IV clinical study analyzes what interactions people have when they take Biotin and Naprosyn. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.



On Aug, 09, 2026

98 people who take Biotin and Naprosyn together, and have interactions are studied.

Biotin and Naprosyn drug interactions.

What are the common drug interactions of Biotin and Naprosyn, by gender? *:

female:

  1. Fall
  2. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  3. Chronic kidney disease
  4. Drug hypersensitivity
  5. Application site pain
  6. Constipation
  7. Lymphocyte count decreased
  8. Small intestinal obstruction (blockage in small intestine)
  9. Depression
  10. Pain in extremity

male:

  1. Hot flush (sudden feelings of heat)
  2. Lacrimation increased
  3. Micturition urgency (urgency to pass the urine)

What are the common drug interactions of Biotin and Naprosyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Hereditary angioedema (recurrent episodes of severe swelling)

20-29:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Sinusitis (inflammation of sinus)
  3. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  4. Implant site erythema (redness at implant site)
  5. Implant site fibrosis
  6. Implant site infection
  7. Implant site inflammation
  8. Pain in extremity
  9. Shoulder operation
  10. Wound

30-39:

n/a

40-49:

  1. Drug hypersensitivity
  2. Lymphocyte count decreased
  3. Abdominal distension
  4. Abdominal pain
  5. Anxiety
  6. Chronic kidney disease
  7. Depression
  8. Device dislocation
  9. Dysmenorrhoea (painful menstruation)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Chondrosarcoma (common form of bone cancer)
  2. Chronic kidney disease
  3. Constipation
  4. Dizziness
  5. Bradycardia (abnormally slow heart action)
  6. Breast cancer metastatic
  7. Breast cancer recurrent
  8. Chorioretinitis (an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina of the eye)
  9. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  10. Disease progression

60+:

  1. Arthralgia (joint pain)
  2. Application site pain
  3. Septic shock (shock due to blood infection)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Muscle spasms (muscle contraction)
  6. Injection site pain
  7. Application site pruritus (application site severe itching of the skin)
  8. Chest pain
  9. Heart rate decreased
  10. Ventricular extrasystoles (premature cardiac contraction)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 14.29%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 10.20%
  3. Hypersensitivity: 9 people, 9.18%
  4. Constipation: 9 people, 9.18%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 8.16%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 8.16%
  7. Depression: 8 people, 8.16%
  8. Stress And Anxiety: 8 people, 8.16%
  9. Nausea (feeling of having an urge to vomit): 7 people, 7.14%
  10. High Blood Pressure: 7 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and Naprosyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Biotin and Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biotin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on biotin and naproxen (the active ingredients of Biotin and Naprosyn, respectively), and Biotin and Naprosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: